Insulet Corp. Surpasses Earnings Expectations
Update: 2025-11-06
Description
Insulet Corporation, a medical device company, reported impressive third-quarter earnings, surpassing analysts predictions with a profit of $87.6 million and $1.24 per share. The companys revenue also exceeded expectations at $706.3 million. These results highlight the growing demand for Insulets innovative insulin infusion systems, essential for managing diabetes, and the companys successful market penetration and customer adoption.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
